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“Take home” message 1 
 2 
Prenatal exposure to maternal stress is associated with increased perception of dyspnea in 3 
adulthood 28 years later. 4 
5 
3 
 
Dyspnea is the aversive cardinal symptom in various prevalent conditions such as respiratory, 1 
cardiovascular and neuromuscular diseases and is associated with great individual and 2 
socioeconomic burden [1]. Over the past years, not only several physiological, but also 3 
psychological factors have been demonstrated to impact the perception of dyspnea [1,2]. For 4 
example, high levels of anxiety in adulthood were associated with increased dyspnea 5 
perception in patients with asthma or chronic obstructive pulmonary disease (COPD), but also 6 
in healthy controls [2]. Moreover, adverse, separation-related experiences in childhood were 7 
linked to the subsequent development of increased anxiety and dyspnea [3]. However, the 8 
effects of adverse experiences in early, prenatal life on dyspnea perception remain widely 9 
unknown, although prenatal exposure to maternal stress and anxiety has convincingly been 10 
related to the development of other health- and behavioral problems later in life, including 11 
impairments of the respiratory control system and high anxiety levels [4–9]. Therefore, this 12 
study investigated the relationship between prenatal exposure to maternal stress and the 13 
perception of dyspnea in adulthood 28 years later. 14 
 15 
Subjects were recruited from the ‘Leuven Cohort’, a longitudinal study that started in 1986 16 
with 86 pregnant mothers and their firstborn children. The study examines the 17 
neurobehavioral effects of prenatal exposure to maternal stress on fetal, infant, and childhood 18 
development, continuing into adulthood [10]. At study entry, the sample of mothers consisted 19 
of healthy Belgian women without history of psychiatric disorders. Maternal stress levels 20 
during pregnancy were operationalized as trait anxiety levels and assessed with the validated 21 
State-Trait-Anxiety-Inventory (STAI)[11]. In addition, the following variables with known 22 
impact on early life development were obtained: duration of pregnancy (days), birth weight 23 
(g), maternal smoking during pregnancy (no. cigarettes/day), maternal caffeine consumption 24 
during pregnancy (mg/day) and maternal alcohol consumption during pregnancy (mg/day). 25 
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 1 
From the original cohort, 40 healthy adults could be included. After obtaining written 2 
informed consent and an anamnestic interview, spirometric lung function was measured. 3 
Additionally, levels of state and trait anxiety, dyspnea-specific anxiety and somatic symptom 4 
burden were assessed with validated questionnaires [11–13]. 5 
 6 
Subsequently, their perception of dyspnea was examined in two magnitude estimation tasks 7 
(MET), during which four inspiratory threshold loads (Respironics, Parsippany, US) with 8 
different resistances (0, 5, 20 and 40 cmH2O/L/s) were repeatedly being presented. Subjects 9 
wore a nose clip and breathed through an antibacterial filter being connected to a two-way, 10 
non-rebreathing valve (Hans Rudolph Inc., Shawnee, US). The inspiratory port was connected 11 
to a tube (diameter: 2cm; length: 150cm) where threshold loads were introduced. In the first 12 
MET, subjects breathed through the loads for one inspiration and rated the intensity of 13 
dyspnea on a Borg-scale [14]. Each load was presented four times in random order. In the 14 
second MET, subjects breathed for five subsequent inspirations through the loads and rated 15 
both the intensity and unpleasantness of dyspnea on a Borg-scale [14]. Each load was 16 
presented twice in random order.  17 
 18 
For the analyses, subjects were grouped into a low prenatal stress group (LS) and a high 19 
prenatal stress group (HS) as in previous studies [10]. Grouping was based on trait anxiety 20 
ratings [11] of their mothers during the 12th to 22nd week of pregnancy (low: <75th vs. 21 
high:=/>75th percentile). Perceptual sensitivity for dyspnea was calculated with individual 22 
regression slopes (Borg scores against load resistance) [15]. Groups were compared with 23 
independent samples t-tests or Mann-Whitney-U-tests, respectively. Additional Spearman 24 
correlations were calculated for dyspnea sensitivity slopes. Data are presented as group means 25 
5 
 
(+SD) and were analyzed using SPSS 24 software (SPSS Inc., Chicago, US) using a statistical 1 
significance threshold of α<0.05.   2 
 3 
Group characteristics including data of the mothers during pregnancy are presented in figure 4 
1a. As expected, trait anxiety ratings of the mothers during the 12th to 22nd week of pregnancy 5 
were significantly different between groups (p<0.001). No significant group differences were 6 
observed in other characteristics of the tested subjects or their mothers (p’s>0.23).  7 
 8 
No significant group differences were observed in the slopes for dyspnea intensity in the first, 9 
single-breath MET (HS: 0.17 + 0.06; LS: 0.15 + 0.07; p=0.53; figure 1b) and in the second, 10 
five-breath MET (HS: 0.20 + 0.03; LS: 0.16 + 0.08; p=0.30; figure 1c). However, the HS 11 
group demonstrated significantly higher slopes for dyspnea unpleasantness than the LS group 12 
(HS: 0.20 + 0.03; LS: 0.15 + 0.08; p<0.01; figure 1d). In addition, the slopes for dyspnea 13 
unpleasantness showed a significant positive correlation with maternal stress levels (rho=0.34, 14 
p<0.05; figure 1e), but not with other variables of the subjects or their mothers (rho’s<0.30, 15 
p’s>0.06).  16 
 17 
The present results suggest that prenatal exposure to maternal stress is associated with 18 
increased perception of dyspnea, especially its affective unpleasantness, in adulthood 28 years 19 
later. This is in line with previous human and animal studies demonstrating that adverse early 20 
life experiences such as being exposed as a fetus to maternal stress, is related to the 21 
development of health- and behavioral problems later in life [4–9]. However, the specific 22 
underlying mechanism for the association between prenatal stress exposure and dyspnea 23 
perception in adulthood observed in the present study remains unclear.  24 
 25 
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Several potentially contributing factors pertaining to current characteristics of the tested 1 
subjects [1,2] including lung function, age, weight, height, gender, general and dyspnea-2 
specific anxiety levels as well as somatic symptom burden were unrelated to the present 3 
findings. Similarly, potential factors related to pregnancy [5,7] such as duration of pregnancy, 4 
birth weight and maternal consumption of cigarette smoke, caffeine and alcohol during 5 
pregnancy were not related to the present findings. Therefore, future studies are required to 6 
test further potential mechanisms that might underlie the observed association between early 7 
life adversity and perception of dyspnea later in life. These studies might include measures of 8 
the autonomic nervous system, the hypothalamic–pituitary–adrenal (HPA)-axis, the 9 
endogenous opioidergic and chemosensitive systems as well as functional and structural 10 
measures of the brain, which have not only been suggested to be impacted by prenatal stress 11 
exposure [5–8], but are also involved in the processing of dyspnea [2,3,9].  12 
 13 
Future studies should also address the limitations of the present study such as the rather small 14 
sample size, which is partly related to the relatively small original cohort. Moreover, the use 15 
of inspiratory threshold loads for the experimental induction of transient dyspnea sensations 16 
only mirrors some facets of dyspnea (ie, ‘increased work and effort of breathing’) [1,2], and 17 
might not be fully comparable to other, more sustained dyspnea experiences outside the lab. 18 
Finally, our findings in healthy, younger adults might not be generalizable to patients that 19 
frequently experience dyspnea, especially when paralleled by older age such as commonly 20 
observed in COPD. Therefore, studies are needed that examine the role of early life adversity 21 
on dyspnea perception later in life in dyspneic patients with respiratory, cardiovascular and 22 
neuromuscular diseases. If the present findings replicate in these future studies, it would not 23 
only improve our knowledge on potential mechanisms involved in dyspnea perception, but 24 
also warrant interventions to reduce maternal stress in pregnancy in order to decrease 25 
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symptom burden in future patients with dyspnea. 1 
 2 
In summary, prenatal exposure to maternal stress is associated with increased perception of 3 
dyspnea in adulthood in healthy subjects. Future studies are needed to examine the underlying 4 
mechanism for this association and the respective effects of early life adversity in patients 5 
suffering from dyspnea. 6 
7 
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Figure legends  1 
 2 
Figure 1.  3 
a) Characteristics of subjects with exposure to low prenatal stress and high prenatal stress 4 
including data of their mothers during pregnancy. Whereas trait anxiety ratings of the mothers 5 
during the 12th to 22nd week of pregnancy are significantly different between groups, there are 6 
no significant group differences in other characteristics.  7 
Perceptual sensitivity for dyspnea expressed as group means (SE) for individual regression 8 
slopes (Borg scores against load resistance) for b) dyspnea intensity during the single breath 9 
MET, c) dyspnea intensity during the five-breath MET and d) dyspnea unpleasantness during 10 
the five-breath MET. e) Significant correlation between perceptual sensitivity for dyspnea 11 
unpleasantness during the five-breath MET (Borg scores against load resistance) and maternal 12 
stress levels (STAI) during the 12th to 22nd week of pregnancy. 13 
FEV1 = forced expiratory volume in 1s;  14 
#analyzed with χ2-test;  15 
ameasured with STAI (State-Trait-Anxiety-Inventory); 16 
bmeasured with BCS (Breathlessness Catastrophizing Scale);  17 
cmeasured with PHQ-15 (Patient Health Questionnaire);  18 
**p < 0.01.  19 
